It has been decided in the light of COVID-19 pandemic outbreak to postpone the 19th ICDRA Conference until next year. Further information will be provided in the the 19th ICDRA website and WHO website on new dates.
Welcome
International Conference of Drug Regulatory Authorities (icdra)
Since it was founded in 1980, the International Conference of Drug Regulatory Authorities (icdra) has brought together regulatory authorities from WHO Member States to strengthen collaboration and develop international consensus on regulatory priorities. icdra provides a unique forum to support and guide regulatory authorities, WHO and international stakeholders in confronting the challenges and highlighting the opportunities of today’s dynamic and innovative regulatory sector.
Delegates from regulatory authorities around the world will participate in an event programme designed to evoke ideas and discussion on the current key priorities in the regulatory environment while also ensuring valuable engagement with leading stakeholders across industry, research as well as healthcare professionals in the open pre-icdra conference.
The 19th icdra will facilitate focused discussions on quality issues, regulatory reforms and strengthening regulatory systems, safety of medical products, detection, prevention and response to substandard and falsified medical products, access to quality medical products, smart regulation of clinical trials, regulatory collaboration, harmonization, rationalization and reliance, access to new and novel technologies, regulation of novel medical products, regulation of herbal medicines, etc.
The theme of the conference is Smart Regulation: Delivering Quality Assured Medical Products for All.
Smart Regulation: Delivering Quality Assured Medical Products for All.
Invitation
To the 19th International Conference of Drug Regulatory Authorities (icdra)
The Central Drugs Standard Control Organization (CDSCO) and the WHO, are delighted to invite you to New Delhi, India, to participate in the 19th International Conference of Drug Regulatory Authorities (icdra).
The conference will be held at the Ashok Hotel, New Delhi, India located in the centre of New Delhi between 28 September and 2 October 2020.
An open pre-conference(pre-icdra) event will be convened from 28 - 29 September 2020 at the same venue.
Dr. Harsh Vardhan
Health Minister, Ministry of Health & Family Welfare (MoHFW)
The Ministry of Health & Family Welfare (MoHFW), Government of India, welcomes the participants and delegates of the "19th International Conference of Drug Regulatory Authorities (icdra), New Delhi, India, 28th September- 2nd October 2020”.
The Ministry of Health believes that the drug regulatory International Conference of Drugs Regulatory Authorities (icdra) Confrence will be great platform where all the regulators will brainstrom various regulatory issues which will help India and the globe to go ahead.
Dr. Preeti Sudan
Secretary, Ministry of Health and Family Welfare
The Ministry of Health & Family Welfare (MoHFW), Government of India, welcomes the participants and delegates of the "19th International Conference of Drug Regulatory Authorities (icdra), New Delhi, India, 28th September- 2nd October 2020". and Conveys its complete support for organisation of the great conference and wishes all success to this conference of regulators.
Dr. V. G. Somani
Drugs Controller General of India (CDSCO) and Chair of the Member State Mechanism (WHO)
Central Drugs Standard Control Organization is privileged to host the 19th International Conference of Drugs Regulatory Authorities (icdra) in New Delhi India from 28th September to 2nd October 2020. As a Drugs Controller General of India and Chair of the Member State Mechanism, I take great pride in welcoming all the eminent Drugs Regulators from all over the world, renowned scientists, academicians, researchers, Business delegates and leading national & international stakeholders to participate in one of the largest and prestigious gatherings for medical product regulation.
Smart and Risk based regulations are the need of the hour in the context of resource, manpower constraints for ensuring quick access to quality assured medical products.
Therefore icdra will provide the right platform where all regulators will share their best practices and bring out rational, acceptable actionable points for the regulatory decision which in turn will increase access to affordable quality assured medical products.
